Principal Financial Group’s Ocular Therapeutix OCUL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,623
| Closed | -$92.5K | – | 2293 |
|
|
2025
Q1 | $92.5K | Sell |
12,623
-797
| -6% | -$5.84K | ﹤0.01% | 2102 |
|
|
2024
Q4 | $115K | Sell |
13,420
-1,141
| -8% | -$9.74K | ﹤0.01% | 2142 |
|
|
2024
Q3 | $127K | Sell |
14,561
-11,803
| -45% | -$103K | ﹤0.01% | 2135 |
|
|
2024
Q2 | $180K | Sell |
26,364
-1,516
| -5% | -$10.4K | ﹤0.01% | 2155 |
|
|
2024
Q1 | $254K | Buy |
27,880
+5,921
| +27% | +$53.9K | ﹤0.01% | 2123 |
|
|
2023
Q4 | $97.9K | Sell |
21,959
-112
| -0.5% | -$500 | ﹤0.01% | 2275 |
|
|
2023
Q3 | $69.3K | Sell |
22,071
-175
| -0.8% | -$550 | ﹤0.01% | 2326 |
|
|
2023
Q2 | $115K | Sell |
22,246
-625
| -3% | -$3.23K | ﹤0.01% | 2270 |
|
|
2023
Q1 | $121K | Sell |
22,871
-1,695
| -7% | -$8.93K | ﹤0.01% | 2272 |
|
|
2022
Q4 | $69K | Buy |
24,566
+4,471
| +22% | +$12.6K | ﹤0.01% | 2343 |
|
|
2022
Q3 | $84K | Sell |
20,095
-476
| -2% | -$1.99K | ﹤0.01% | 2360 |
|
|
2022
Q2 | $83K | Buy |
20,571
+6,536
| +47% | +$26.4K | ﹤0.01% | 2411 |
|
|
2022
Q1 | $69K | Buy |
14,035
+999
| +8% | +$4.91K | ﹤0.01% | 2468 |
|
|
2021
Q4 | $91K | Sell |
13,036
-132,705
| -91% | -$926K | ﹤0.01% | 2448 |
|
|
2021
Q3 | $1.46M | Buy |
145,741
+541
| +0.4% | +$5.41K | ﹤0.01% | 1924 |
|
|
2021
Q2 | $2.06M | Buy |
145,200
+115,671
| +392% | +$1.64M | ﹤0.01% | 1901 |
|
|
2021
Q1 | $484K | Sell |
29,529
-836
| -3% | -$13.7K | ﹤0.01% | 2161 |
|
|
2020
Q4 | $628K | Buy |
+30,365
| New | +$628K | ﹤0.01% | 2053 |
|
|
2015
Q2 | – | Sell |
-54,000
| Closed | -$2.27M | – | 2203 |
|
|
2015
Q1 | $2.27M | Sell |
54,000
-70,000
| -56% | -$2.94M | ﹤0.01% | 1630 |
|
|
2014
Q4 | $2.92M | Buy |
+124,000
| New | +$2.92M | ﹤0.01% | 1597 |
|